These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11941213)

  • 1. Neuroleptic Malignant Syndrome: Neuroleptic Rechallenge After Electroconvulsive Therapy.
    Hanin B; Lerner Y
    Convuls Ther; 1993; 9(3):198-204. PubMed ID: 11941213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients.
    Rosebush PI; Stewart TD; Gelenberg AJ
    J Clin Psychiatry; 1989 Aug; 50(8):295-8. PubMed ID: 2569457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome.
    Davis JM; Janicak PG; Sakkas P; Gilmore C; Wang Z
    Convuls Ther; 1991; 7(2):111-120. PubMed ID: 11941110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple ECT late in the course of neuroleptic malignant syndrome.
    McKinney P; Kellner C
    Convuls Ther; 1997 Dec; 13(4):269-73. PubMed ID: 9437570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive Therapy in the Neuroleptic Malignant Syndrome.
    Casey DA
    Convuls Ther; 1987; 3(4):278-283. PubMed ID: 11940929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Choice in Neuroleptic Malignant Syndrome.
    Scheftner WA; Shulman RB
    Convuls Ther; 1992; 8(4):267-279. PubMed ID: 11941178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases.
    Trollor JN; Sachdev PS
    Aust N Z J Psychiatry; 1999 Oct; 33(5):650-9. PubMed ID: 10544988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K; Warchala A
    Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive Therapy of the Lethal Catatonia Syndrome.
    Mann SC; Caroff SN; Bleier HR; Antelo RE; Un H
    Convuls Ther; 1990; 6(3):239-247. PubMed ID: 11941074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive Therapy for Neuroleptic Malignant Syndrome: A Case Series.
    Morcos N; Rosinski A; Maixner DF
    J ECT; 2019 Dec; 35(4):225-230. PubMed ID: 31764444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECT during and after the neuroleptic malignant syndrome: case report.
    Hughes JR
    J Clin Psychiatry; 1986 Jan; 47(1):42-3. PubMed ID: 3941060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome: a life-threatening complication that can be treated effectively].
    van Waarde JA; Muller ME; Verweg B
    Ned Tijdschr Geneeskd; 2006 Nov; 150(46):2517-20. PubMed ID: 17152323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified ECT Using Succinylcholine After Remission of Neuroleptic Malignant Syndrome.
    Devanand DP; Sackeim HA; Finck AD
    Convuls Ther; 1987; 3(4):284-290. PubMed ID: 11940930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery and rechallenge after the neuroleptic malignant synorome.
    Chopra MP; Raguram R
    Indian J Psychiatry; 2001 Jan; 43(1):41-5. PubMed ID: 21407837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome in Mexico.
    Montoya A; Ocampo M; Torres-Ruiz A
    Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.